ITUA20161346A1 - Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione - Google Patents

Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione

Info

Publication number
ITUA20161346A1
ITUA20161346A1 ITUA2016A001346A ITUA20161346A ITUA20161346A1 IT UA20161346 A1 ITUA20161346 A1 IT UA20161346A1 IT UA2016A001346 A ITUA2016A001346 A IT UA2016A001346A IT UA20161346 A ITUA20161346 A IT UA20161346A IT UA20161346 A1 ITUA20161346 A1 IT UA20161346A1
Authority
IT
Italy
Prior art keywords
carbossamids
pyrrol
oxo
derivatives
production
Prior art date
Application number
ITUA2016A001346A
Other languages
English (en)
Inventor
Ca' Nicola Della
Roberto Romeo
Beatrice Macchi
Antonio Mastino
Salvatore Vincenzo Giofre'
Bartolo Gabriele
Original Assignee
Univ Degli Studi Di Parma
Univ Degli Studi Della Calabria
Univ Degli Studi Di Roma “Tor Vergata”
Consiglio Nazionale Ricerche
Univ Degli Studi Di Messina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Parma, Univ Degli Studi Della Calabria, Univ Degli Studi Di Roma “Tor Vergata”, Consiglio Nazionale Ricerche, Univ Degli Studi Di Messina filed Critical Univ Degli Studi Di Parma
Priority to ITUA2016A001346A priority Critical patent/ITUA20161346A1/it
Priority to PCT/IB2017/051261 priority patent/WO2017149511A1/en
Priority to EP17718413.2A priority patent/EP3423053A1/en
Publication of ITUA20161346A1 publication Critical patent/ITUA20161346A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITUA2016A001346A 2016-03-04 2016-03-04 Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione ITUA20161346A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITUA2016A001346A ITUA20161346A1 (it) 2016-03-04 2016-03-04 Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione
PCT/IB2017/051261 WO2017149511A1 (en) 2016-03-04 2017-03-03 Use of 2-oxo-2h-pyrrol-1(5h)-carboxamide derivatives as anti-hiv agents and process for the production thereof
EP17718413.2A EP3423053A1 (en) 2016-03-04 2017-03-03 Use of 2-oxo-2h-pyrrol-1(5h)-carboxamide derivatives as anti-hiv agents and process for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A001346A ITUA20161346A1 (it) 2016-03-04 2016-03-04 Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione

Publications (1)

Publication Number Publication Date
ITUA20161346A1 true ITUA20161346A1 (it) 2017-09-04

Family

ID=56203484

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A001346A ITUA20161346A1 (it) 2016-03-04 2016-03-04 Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione

Country Status (3)

Country Link
EP (1) EP3423053A1 (it)
IT (1) ITUA20161346A1 (it)
WO (1) WO2017149511A1 (it)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2320742A1 (fr) * 1975-08-13 1977-03-11 Isf Spa Derives pyrroliniques et leur application pharmacologique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2320742A1 (fr) * 1975-08-13 1977-03-11 Isf Spa Derives pyrroliniques et leur application pharmacologique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PACE P ET AL: "4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, vol. 18, no. 14, 15 July 2008 (2008-07-15), pages 3865 - 3869, XP022852851, ISSN: 0960-894X, [retrieved on 20080620], DOI: 10.1016/J.BMCL.2008.06.056 *

Also Published As

Publication number Publication date
EP3423053A1 (en) 2019-01-09
WO2017149511A1 (en) 2017-09-08

Similar Documents

Publication Publication Date Title
NI201700128A (es) Composiciones de acido obeticolico y metodos de uso.
BR112017025266A2 (pt) processo para produzir brivaracetam
IT201800009683A1 (it) Processo per la preparazione di 3α-idrossi-5α-pregnan-20-one (brexanolone)
DE112016000901A5 (de) Verfahren zur Herstellung von optoelektronischen Halbleiterbauteilen und optoelektronisches Halbleiterbauteil
IT201600105178A1 (it) Procedimento per la produzione di dieni
BR112017026560A2 (pt) processo para preparação de apremilast e seus intermediários.
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
IT201700068744A1 (it) Processo per la produzione di acido levulinico.
ITUB20160155A1 (it) Processo per la produzione di amido da microalghe
IT201600130642A1 (it) Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo
IT201700090690A1 (it) Procedimento e macchina per la produzione di forme di dosaggio
SMT201700113B (it) Derivati fotoreticolati di acido ialuronico, loro processo di preparazione ed impiego
CL2016003144A1 (es) Método y composición para mejorar la productividad de plantas no leguminosas
ITUA20161691A1 (it) Metodo per la produzione di elettrodi per dispositivi elettrochimici
IT201600092469A1 (it) Processo per la produzione di Blonanserina
IT201600130538A1 (it) Processo per la produzione del delmopinolo
ITUA20161346A1 (it) Uso di derivati 2-oxo-2h-pirrol-1(5h)-carbossamidici come agenti anti-hiv e processo per la loro produzione
ITUA20161550A1 (it) Procedimento per la produzione di RNA
IT201700101039A1 (it) Processo di preparazione di cemento bioareato autoclavato
IT201700090748A1 (it) Processo e impianto di produzione di urea facenti uso di co2 prodotta tramite ossi-combustione
DE102015214381A8 (de) Abtragsoptimierte bearbeitung von optischen elementen
BR112016026814A2 (pt) 2,2,2-trifluoroetil-tiadiazinas, intermediário, seu uso e seu processo de preparação, e composição farmacêutica
IT201700004904A1 (it) PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
ITVI20130143A1 (it) Processo migliorato per la preparazione di 3-amminopiperidina e suoi derivati
IT201600132329A1 (it) Processo per la preparazione di superfici aventi proprietà antimicrobiche